China’s Top Pharma Firms Prosper; Private Innovators Likely To Lead Sector
This article was originally published in PharmAsia News
Executive Summary
BEIJING - China's strengthening regulation of the pharmaceutical sector and expanding national health insurance coverage, along with rising incomes, are all triggering a boom for the country's leading drug makers, according to a new study of the sector
You may also be interested in...
Despite Global Crisis, China’s Strongest Pharma Firms Likely To Thrive In 2009 Through Innovation And Acquisitions
BEIJING - Despite the Western world's financial meltdown and China's own faltering economic growth rates, the country's leading pharmaceutical companies are forecast to expand through 2009 by developing innovative drugs and by outlasting or even merging with their weakest competitors
Despite Global Crisis, China’s Strongest Pharma Firms Likely To Thrive In 2009 Through Innovation And Acquisitions
BEIJING - Despite the Western world's financial meltdown and China's own faltering economic growth rates, the country's leading pharmaceutical companies are forecast to expand through 2009 by developing innovative drugs and by outlasting or even merging with their weakest competitors
China Medicine To Enter U.S. Market With Weight Loss Tablets
BEIJING - China Medicine Corp. is preparing to launch its first product in the U.S., a dietary supplement aimed at weight loss and countering obesity, according to the company's CEO